Nurix Therapeutics
NRIX
NRIX
163 hedge funds and large institutions have $1.01B invested in Nurix Therapeutics in 2025 Q2 according to their latest regulatory filings, with 23 funds opening new positions, 69 increasing their positions, 43 reducing their positions, and 31 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
163
Holders Change
-8
Holders Change %
-4.68%
% of All Funds
2.19%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.01%
New
23
Increased
69
Reduced
43
Closed
31
Calls
$1.72M
Puts
$173K
Net Calls
+$1.55M
Net Calls Change
+$867K
Top Buyers
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
$42.2M |
| 2 |
UBS Group
Zurich,
Switzerland
|
$18.1M |
| 3 |
VPC
Vestal Point Capital
New York
|
$22.8M |
| 4 |
PA
Perceptive Advisors
New York
|
$12.5M |
| 5 |
Morgan Stanley
New York
|
$24.7M |
